http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013128607-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
| filingDate | 2011-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013128607-A |
| titleOfInvention | PHARMACEUTICAL COMPOSITIONS CONTAINING CORTICOSTEROIDS FOR TOPICAL USE |
| abstract | 1. A pharmaceutical composition for topical use on an individual’s skin, comprising a corticosteroid selected from the group consisting of the ingredients shown in Table 1 of this description, with a lower concentration than the lowest concentration indicated in Table 1 for a corticosteroid, and a liquid oil component comprising one or more esters of monocarboxylic and dicarboxylic acids, wherein at least 25% of the corticosteroid is dissolved in the liquid oil component at room temperature, and the concentration of esters in liquid m the asl component comprises at least 10% of the concentration of the liquid oil component in the composition. The pharmaceutical composition of claim 1, wherein the corticosteroid is selected from the group consisting of clobetasol propionate, betamitazone dipropionate, halobetazole propionate, diflorazone diacetate, fluocinonide and deoxymethasone with a concentration of less than 0.05%, or selected from the group consisting of beclomethasone and budesonide with a concentration of less than 0.025%, or selected from the group consisting of mometasone furoate and halcinonide with a concentration of less than 0.1%. 3. The pharmaceutical composition of claim 2, wherein the corticosteroid is a corticosteroid selected from the group consisting of clobetasol propionate, betamitazone dipropionate, halobetazole propionate, and fluocinonide. The pharmaceutical composition of claim 1, wherein the corticosteroid is a corticosteroid selected from the group consisting of betamethasone dipropionate, mometasone furoate, diphlorazone acetate, galcinonide, fluocinonide and deoxymethasone. The pharmaceutical composition of claim 1, wherein the concentration of the corticosteroid is 0.025% or less. |
| priorityDate | 2010-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.